These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1086087)

  • 21. Tobramycin inhalation solution (Bethkis) for cystic fibrosis.
    Med Lett Drugs Ther; 2014 Jun; 56(1445):51-2. PubMed ID: 24956309
    [No Abstract]   [Full Text] [Related]  

  • 22. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of netilmicin and tobramycin therapy in patients with renal impairment.
    Gorse GJ; Bernstein JM; Cronin RE; Etzell PS
    Scand J Infect Dis; 1992; 24(4):503-14. PubMed ID: 1411317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.
    Chuchalin A; Csiszér E; Gyurkovics K; Bartnicka MT; Sands D; Kapranov N; Varoli G; Monici Preti PA; Mazurek H
    Paediatr Drugs; 2007; 9 Suppl 1():21-31. PubMed ID: 17536872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin].
    Friis B; Thomsen J
    Ugeskr Laeger; 1979 Jul; 141(29):1968-72. PubMed ID: 545764
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute renal failure associated with inhaled tobramycin.
    Cannella CA; Wilkinson ST
    Am J Health Syst Pharm; 2006 Oct; 63(19):1858-61. PubMed ID: 16990632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobramycin: in vitro and clinical evaluation in 30 patients.
    Perkins RL; Saslaw S; Fass RJ; Prior RB; Scholand JF; Hodges GR; Tight RR; Gardner WG
    Am J Med Sci; 1976; 271(3):297-308. PubMed ID: 820196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
    Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A
    Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.
    Lerner AM; Reyes MP; Cone LA; Blair DC; Jansen W; Wright GE; Lorber RR
    Lancet; 1983 May; 1(8334):1123-6. PubMed ID: 6133153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of long term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease.
    Paporisz U; Posselt HG; Wönne R; Ristow W; Röser D; Knothe H; Bender SW
    Eur J Pediatr; 1979 Apr; 130(4):259-69. PubMed ID: 436850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective evaluation of vestibular and auditory function in 76 patients treated with netilmicin.
    Tjernström O
    Scand J Infect Dis Suppl; 1980; Suppl 23():122-5. PubMed ID: 6970983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous infusion tobramycin combined with carbenicillin for infections in cancer patients.
    Issell BF; Keating MJ; Valdivieso M; Bodey GP
    Am J Med Sci; 1979; 277(3):311-8. PubMed ID: 256433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Tobramycin Prophylaxis Prior to Colorectal Surgery Is Not Associated with Systemic Uptake.
    Mulder T; Kluytmans-van den Bergh MFQ; Crolla RMPH; Ermens AAM; Romme J; Van't Veer NE; Kluytmans JAJW
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.
    Mulheran M; Hyman-Taylor P; Tan KH; Lewis S; Stableforth D; Knox A; Smyth A
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2293-9. PubMed ID: 16801404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
    O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
    Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative toxicity of gentamicin versus tobramycin: a randomized prospective study.
    Fong IW; Fenton RS; Bird R
    J Antimicrob Chemother; 1981 Jan; 7(1):81-8. PubMed ID: 7204294
    [No Abstract]   [Full Text] [Related]  

  • 37. Bronchial constriction after nebulized tobramycin preparations and saline in patients with cystic fibrosis.
    Nikolaizik WH; Jenni-Galović V; Schöni MH
    Eur J Pediatr; 1996 Jul; 155(7):608-11. PubMed ID: 8831087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobramycin nephrotoxicity. A prospective clinical study.
    Coca A; Blade J; Martinez A; Segura F; Soriano E; Ribas-Mundo M
    Postgrad Med J; 1979 Nov; 55(649):791-6. PubMed ID: 523366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tobramycin inhalation powder (Tobi Podhaler) for cystic fibrosis.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):51-2. PubMed ID: 23797798
    [No Abstract]   [Full Text] [Related]  

  • 40. Possible tobramycin delirium.
    McCartney CF; Hatley LH; Kessler JM
    JAMA; 1982 Mar; 247(9):1319. PubMed ID: 7062552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.